Product Name | Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372) |
---|---|
CAS | 2171511-58-1 |
Storage condition | -20°C for 3 years | In solvent: -80°C for 1 year |
Amivantamab (JNJ-61186372) is a fully human EGFR-MET bispecific antibody that combats resistance in NSCLC through multifaceted mechanisms: ligand blockade, receptor degradation, and immune cell activation, including ADCC and trogocytosis. This innovative approach targets both primary and acquired resistance, offering a new therapeutic avenue for patients with EGFR and MET aberrations.
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft